When to Start A1c Screening? (Age and Risk Factors)

When to Start A1c Screening? (Age and Risk Factors)

The rest of this page explains where those triggers come from, what shifts them, and why two people the same age can end up on very different testing intervals.

What does hemoglobin A1C actually measure?

Hemoglobin A1C measures the proportion of hemoglobin inside your red blood cells that has glucose chemically attached to it, which reflects average blood sugar exposure over the previous few months rather than at a single moment. Because red cells live a limited lifespan, the number moves slowly and is not thrown off by one large meal or one stressful morning. It is a single blood draw and does not require fasting.

The full picture of what the marker is, how it is run, where the ranges sit and how to read a result lives on the Hemoglobin A1C page. Everything below is about timing instead: who starts screening, at what age, how often a normal result is repeated, and who decides.

Why does the starting age matter at all?

The starting age matters because raised blood sugar produces no reliable symptoms for years, so the first opportunity to notice it is a test rather than a feeling. Screening means testing people who feel well, on the assumption that some of them are already drifting. That is a different exercise from testing someone who has arrived with thirst, weight loss or blurred vision, where the question is confirmation rather than discovery.

Prediabetes and early type 2 diabetes are commonly identified through routine screening rather than through symptoms, which is why guideline groups set age and risk triggers at all 2. If there were a dependable early warning sign, the schedule would be unnecessary.

A starting age is a compromise. Begin too early across the whole population and most results come back normal, which costs money and generates follow-up for people who were never at meaningful risk. Begin too late and a slow drift that started in a person's thirties goes unrecorded until it is well established. Guideline committees pick the age band where the yield of testing starts to justify the effort for a large number of people, then layer risk-based exceptions on top for everyone whose situation does not fit the average.

That structure matters for how you read any recommendation. The age is the default for an adult with no particular reason to test sooner. It is not a rule that testing before that birthday is pointless, and it is not permission to skip the conversation if something in your history suggests otherwise.

At what age do the main screening recommendations begin?

For adults who are not pregnant, the most widely cited benchmark is age 35. The US Preventive Services Task Force recommends screening for prediabetes and type 2 diabetes in adults aged 35 to 70 years who have overweight or obesity 1. Two conditions sit inside that single sentence, an age band and a body weight criterion, and both do work.

The upper end of the band, age 70, is not a statement that older adults stop mattering. It reflects the population in which the recommendation was assessed. Testing beyond that age is a judgement call made with a clinician, weighing what would actually change as a result.

It is also worth knowing that recommendations are not identical across organisations. Screening guidance differs between groups in the exact age thresholds and risk criteria used, which is one reason two clinicians can give slightly different advice while both being reasonable 2. The practical version for most adults is simple enough. Somewhere in the mid-thirties, a first check of A1c or fasting glucose becomes a routine part of adult care, and before then it becomes routine only if something in your history pulls it forward.

One more framing point. Screening is not diagnosis. A screening result that falls outside the usual range is a signal to look more carefully, usually with a repeat or a second type of test, not a label.

Which risk factors pull the first test earlier than 35?

Several common factors move the first test earlier, and most of them are things you already know about yourself. The Task Force advises considering screening at an earlier age in people from population groups with higher prevalence, and in people with a family history of diabetes, a history of gestational diabetes, or polycystic ovary syndrome 1.

Family history is the one people raise most often. A parent or sibling with type 2 diabetes does not mean the same outcome is waiting for you, but it changes the arithmetic enough that waiting until a birthday on a chart is a weaker plan than testing and finding out.

A pregnancy affected by high blood sugar is another strong trigger. It identifies a metabolism that was already under strain under load, and the relevance does not end when the pregnancy does, which is why that history appears in screening guidance as a reason to start earlier 1.

Polycystic ovary syndrome sits in the same list 1. So do the broader cardiometabolic risk factors that clinicians weigh together, including raised blood pressure, an unfavourable lipid pattern, low physical activity and existing cardiovascular disease, all of which feed into the risk-based criteria used in diabetes screening 2.

None of these makes testing urgent on its own. What they do is shift the default. If you are 29 with two of them, the sensible conversation is about testing now and setting an interval, rather than about waiting six years because a guideline mentions a number.

Why does body weight sit inside the screening trigger?

Body weight sits in the trigger because the recommendation was written for the group in which screening was studied most closely, adults aged 35 to 70 with overweight or obesity 1. Overweight and obesity are defined by body mass index, with 25 and 30 as the conventional thresholds, and those cut points are what the age band is paired with.

Two caveats are worth carrying with you. The first is that body mass index is a crude instrument. It does not know the difference between muscle and fat, and it says nothing about where body fat sits. A person can meet the threshold and have entirely unremarkable glucose handling, and a person can fall well under it and not.

The second is that the same number does not mean the same thing in every population. Risk at a given body mass index varies between population groups, which is part of why screening guidance also points to earlier testing in groups with higher prevalence 1.

So treat the weight criterion as a prompt, not a gate. A normal body mass index is not a reason to decline a test that is otherwise indicated by family history, a prior pregnancy affected by high blood sugar, or a previous borderline result. The threshold exists to identify a large group who benefit from routine screening, not to exclude everyone else.

Is A1c the right screening test, or is fasting glucose better?

Both are accepted screening tests, they measure different things, and they do not always agree. A1c summarises glucose exposure over months. A fasting plasma glucose captures a single morning after an overnight fast. An oral glucose tolerance test watches how the body handles a measured glucose load over a couple of hours.

Test Fasting required What it captures Practical notes
Hemoglobin A1C No Average glucose exposure over the preceding months Convenient, stable day to day, can be shifted by conditions that alter red blood cell lifespan
Fasting plasma glucose Yes, usually 8 hours Blood glucose at one moment after an overnight fast Sensitive to timing, illness and the previous evening, so a single value varies more
Oral glucose tolerance test Yes, plus a timed glucose drink How glucose is handled after a defined load Takes around two hours in the lab, less convenient, picks up patterns the other two can miss

Research suggests that measuring glucose and A1c together identifies people whom either measurement alone would miss, because the two tests do not flag the same individuals 3. That is the practical argument for drawing both when the question is open rather than choosing a favourite.

There is also a known convenience trade. A1c needs no fasting and has less day to day variation than a single glucose reading, which is a large part of why it entered routine screening, alongside practical limitations that have to be respected 4. Which test a clinician orders depends on what else is being drawn that morning, what your history suggests, and whether a previous result needs clarifying.

Where do the numbers sit, and how soon is a normal result repeated?

A normal screening result in an adult with no additional concerns is commonly repeated every three years, and the numbers below are the reference points used to decide that. Screening every three years may be a reasonable approach for adults with normal blood glucose levels 1.

Marker Typical lab reference range FitScript optimal range
Hemoglobin A1C 4 to 5.7 % 4.6 to 5.3 %

Typical lab reference ranges vary by laboratory, age and sex, so read your own report against the range printed on it. FitScript's optimal range is an optimization target, not a diagnostic cut-off, and a value outside it is a prompt for a conversation rather than a label.

Above the standard range, labs commonly regard 5.7 to 6.4 percent as the band flagged as prediabetes, and 6.5 percent or higher as the threshold at which diabetes is considered, confirmed on repeat testing rather than on one sample 4.

The three year interval is a default for a clear result in a person without risk factors. Clinicians shorten it routinely. A result sitting at the top of the normal range, a family history, a recent change in weight or a pregnancy history can all turn three years into one, and the trend across repeated tests often tells you more than any single value. A result moving steadily upward inside the normal range is still a result moving steadily upward.

What happens when a result lands in the prediabetes band?

A result in the prediabetes band is not a diagnosis of diabetes, and the usual response is a repeat test plus a conversation, not alarm. The band exists precisely because it identifies people who are early enough that the situation is still being watched rather than managed, and identifying that group is one of the stated purposes of screening 2.

In practice, three things tend to follow. The first is confirmation, because a single value is a snapshot of a measurement as much as of you. The second is a second type of test, often a fasting glucose alongside the A1c, since the two can disagree 3. The third is a shorter interval, so the next result shows direction rather than a lone dot on a chart.

Direction is the thing to watch. A value of 5.8 that was 5.8 three years ago reads differently from a value of 5.8 that was 5.2 last year, even though the two reports look identical. That is why clinicians ask for old results and why keeping your own copies is worth the small effort.

What a prediabetes range result is not is a reason to ignore the report or to self-manage from an internet search. Any next step, and whether any treatment is appropriate at all, is a decision for a licensed provider who can see your full history.

Can a single A1c result settle anything on its own?

No single screening result settles anything, which is why confirmation on a separate sample is standard practice before any conclusion is drawn 4. Laboratory measurements carry some variation, biology carries more, and screening is designed to be sensitive, which means it will flag some people whose repeat test comes back unremarkable.

Disagreement between tests is common rather than exceptional. Glucose and A1c measurements contribute differently in screening and each identifies people the other does not 3. A person can sit in the prediabetes band by A1c and in the normal range by fasting glucose, or the reverse, and neither result is an error.

That is also why a result should be read with the rest of the picture. Recent illness, a change in weight, a new sleep pattern, a period of unusual stress and a recent blood donation can all sit behind a number that looks different from last year. A clinician reading your result alongside your history is interpreting a trend in a person, not scoring a number.

The corollary matters just as much. A reassuring screening result does not cancel symptoms. If you feel unwell in ways that fit raised blood sugar, say so, regardless of what the last report said.

What can push an A1c reading away from true average glucose?

Anything that changes how long red blood cells survive can move an A1c reading away from the average glucose it is meant to represent, since the test depends on red cell lifespan. Practical considerations in using A1c include hemoglobin variants, anemia and other conditions affecting red blood cells, all of which can distort the result 4.

In people with a hemoglobin variant, some assay methods report a value that does not match their actual glucose exposure, and the laboratory method used matters. In people with anemia, recent significant blood loss, a recent transfusion, or conditions that shorten red cell survival, the reading can be pulled in either direction depending on the mechanism 4. Advanced kidney disease and pregnancy are also situations where clinicians lean more on glucose measurements and less on A1c alone.

None of this makes A1c unreliable as a screening tool. It makes context necessary. If your clinician asks what look like unrelated questions about anemia, recent donations or family blood conditions before interpreting a result, that is why.

It is also a reason the complete blood count drawn alongside is not filler. Red cell indices give the person reading your A1c the information needed to judge whether the value should be taken at face value or checked against a glucose measurement.

Why do A1c and glucose sometimes disagree across populations?

They disagree because the two tests measure different biology, and the gap between them is not the same everywhere. Studies indicate that estimates of diabetes diagnosis and prevalence differ depending on whether fasting glucose or A1c is used, with the pattern varying substantially between world regions and populations 5.

That has a direct consequence for screening. Whether a given person is flagged can depend on which test their clinician ordered, which is an argument for drawing both when the answer matters and for not assuming that a single normal value closes the question.

Population level work using A1c as the screening test has examined how well it identifies prediabetes and diabetes in general adult populations, and A1c-based screening is associated with a different pattern of detection compared with glucose-based criteria in that setting 6. In plain terms, swapping the test swaps some of the people who get picked up.

For you as an individual, the useful takeaway is modest but real. Ask which test was run, keep the result, and if a borderline value shows up, expect your clinician to want a second kind of measurement rather than a repeat of the same one. That is good practice, not indecision.

Does screening look different around pregnancy?

Yes. The general adult screening recommendation described above is written for adults who are not pregnant 1, and glucose testing during pregnancy follows a separate obstetric pathway with its own timing and its own tests, directed by the clinician managing the pregnancy.

The part that connects back to this page is what happens afterwards. A history of gestational diabetes is listed as a reason to consider screening at an earlier age than the usual trigger 1. That history does not expire. Years later it is still a legitimate reason to raise testing with a clinician, even in the absence of symptoms and even at a body weight that would otherwise not prompt it.

If you are planning a pregnancy, the sequencing conversation is worth having early rather than late, because what is useful to know beforehand is different from what gets tested during. And if you are currently pregnant, the timing of any glucose testing is set by your obstetric team, not by general adult screening intervals.

Which other markers are worth running alongside?

A1c is most informative when it is not the only number on the page, because glucose handling is one part of a connected metabolic picture. A fasting glucose drawn at the same time gives a second, independent view, and the two together catch more than either alone 3.

FitScript membership includes 150+ biomarkers tested per year, with interpretation from Atlas, FitScript's AI health advisor, which is one way to see A1c in the context of the markers around it rather than as an isolated value. What any individual should do about a result is a separate question, and a licensed provider decides whether any treatment is appropriate after reviewing the person.

The principle here is simple. Single markers answer narrow questions. A1c tells you about average glucose exposure. It does not tell you why, and the surrounding markers are where the why usually starts to appear.

How does a clinician decide your personal schedule?

A clinician builds your schedule from the default interval and then adjusts it using everything the guideline could not know about you. The starting points are age, body weight and whether any risk-based criteria apply 1, and the adjustments come from your previous results, your family history, your pregnancy history, other conditions you are managing, and what has changed since the last draw.

Trend carries real weight in that decision. Two results three years apart that sit at 5.1 and 5.1 support a relaxed interval. The same two results at 5.1 and 5.6 do not, even though both final values are inside the standard range. A clinician is reading a direction, not grading a single number.

Practical circumstances count too. A significant change in weight, a new diagnosis, a period of disrupted sleep or a planned pregnancy can all justify testing sooner than the calendar suggests. So can symptoms, which override any interval.

This page is educational and is not medical advice. Discuss your own results, your screening interval and any treatment decision with a clinician or licensed provider who can see your full history.

When is a result or a symptom worth raising promptly?

Some situations should not wait for the next scheduled test. Unusual thirst, passing urine far more often than normal, unexplained weight loss, persistent fatigue, blurred vision, or wounds that heal slowly are all worth discussing with a clinician promptly, whatever your last screening result said.

A screening value well above the standard range is also worth raising promptly rather than filing until the next annual visit. That is not a reason for panic, and it is not a diagnosis, since confirmation on a repeat sample is part of standard practice 4. It is a reason to get the repeat booked and the result interpreted by someone who can see your whole record.

The opposite error is more common and quieter. A result that sits just outside the usual range often gets mentally downgraded to nothing, and then nobody looks again for three years. Never ignore an out-of-range result. Flag it, ask what the repeat interval should be, and write the date down.

If you are already under the care of a clinician for a metabolic concern, follow the schedule they set for you rather than a general interval from a guideline or an article.

If you want to go deeper on the marker itself, the companion pieces cover the two questions readers ask next, with is hemoglobin a1c 5 7 bad explaining how that borderline value is read, and how to lower your hemoglobin a1c covering the levers people discuss with a clinician after a raised result.

Key takeaways

References

  1. Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement. JAMA, 2021.
  2. Screening for Diabetes and Prediabetes. Endocrinology and Metabolism Clinics of North America, 2021.
  3. Contributions of Glucose and Hemoglobin A1c Measurements in Diabetes Screening. American Journal of Clinical Pathology, 2022.
  4. Hemoglobin A1c for the diagnosis of diabetes: practical considerations. Polskie Archiwum Medycyny Wewnetrznej, 2010.
  5. Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c. Nature Medicine, 2023.
  6. Haemoglobin A1c-based screening for prediabetes and diabetes mellitus: a multi-center study in Croatian adult population. Biochemia Medica, 2022.

Common questions

At what age does A1c screening usually start?

For adults who are not pregnant, age 35 is the commonly used starting point, paired with a body weight criterion in the most widely cited recommendation. Risk factors such as a family history of diabetes or a past pregnancy affected by high blood sugar can move that first test earlier. Your clinician sets the actual starting point based on your history.

Do I need to fast before an A1c test?

No. A1c reflects average glucose exposure over the preceding months, so it can be drawn at any time of day and does not require fasting. A fasting plasma glucose does require an overnight fast, usually around eight hours, so if both are ordered on the same morning, follow the fasting instruction for the glucose test.

How often should A1c be repeated if the result is normal?

Every three years is the usual interval for an adult with a normal result and no additional concerns. Clinicians shorten it often, for example when a value sits near the top of the normal range, when the trend is rising across tests, or when weight, pregnancy history or a new condition changes the picture.

Does one high A1c result mean I have diabetes?

No. A screening result is a signal to look more closely, not a diagnosis. Standard practice is to confirm on a separate sample, often alongside a glucose measurement, before anything is concluded. Only a clinician reviewing your full record can interpret what a raised value means for you, and what should happen next.

What should I do if my A1c comes back at 5.7?

Book the follow-up rather than filing the report. A value at the lower edge of the flagged band usually leads to a repeat test, often with a fasting glucose drawn at the same time, and a shorter interval before the next check. Bring any previous results, because the direction of travel matters as much as the single number.

Can an A1c result be inaccurate?

It can be shifted away from your true average glucose by anything that changes red blood cell lifespan, including hemoglobin variants, anemia, recent significant blood loss or a recent transfusion. Advanced kidney disease and pregnancy are also situations where clinicians rely more on direct glucose measurements. Tell your clinician if any of these apply to you.

Should younger adults ever be screened?

Yes, when something in their history justifies it. A family history of diabetes, a previous pregnancy affected by high blood sugar, polycystic ovary syndrome, membership of a population group with higher prevalence, or other cardiometabolic risk factors are all reasons to raise testing before the usual age. The decision belongs to a clinician who knows your history.

Is fasting glucose a better screening test than A1c?

Neither is simply better, because they measure different things and do not flag the same people. A1c summarises months of glucose exposure and needs no fasting. Fasting glucose captures one morning and is more sensitive to recent circumstances. Drawing both gives a fuller view, and your clinician decides which to order and when.

Related reading